Evidence map›Paper›PMID 38352680›Full record

ArticleRSC advances2024

First total synthesis of caerulomycin K: a case study on selective, multiple C-H functionalizations of pyridines.

Alessandro Dimasi, Mattia Failla, Arianna Montoli, Andrea Citarella, Paolo Ronchi, Daniele Passarella, Valerio Fasano

Open access · goldAbstract read
In one paragraph

Article in RSC advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Marine natural products.Natural product reports · 2026
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Alessandro DimasiDepartment of Chemistry, Università degli Studi di Milano Via Camillo Golgi, 19 20133 Milano Italy valerio.fasano@unimi.it https://www.fasanolab.com.ORCID https://orcid.org/0009-0008-0211-9327
Mattia FaillaDepartment of Chemistry, Università degli Studi di Milano Via Camillo Golgi, 19 20133 Milano Italy valerio.fasano@unimi.it https://www.fasanolab.com.ORCID https://orcid.org/0009-0004-5556-8063
Arianna MontoliDepartment of Chemistry, Università degli Studi di Milano Via Camillo Golgi, 19 20133 Milano Italy valerio.fasano@unimi.it https://www.fasanolab.com.ORCID https://orcid.org/0009-0008-1317-2158
Andrea CitarellaDepartment of Chemistry, Università degli Studi di Milano Via Camillo Golgi, 19 20133 Milano Italy valerio.fasano@unimi.it https://www.fasanolab.com.ORCID https://orcid.org/0000-0001-5881-7142
Paolo RonchiMedicinal Chemistry and Drug Design Technologies Department, Global Research and Preclinical Development, Chiesi Farmaceutici S.p.A Largo Francesco Belloli 11/a 43126 Parma Italy.ORCID https://orcid.org/0000-0001-5496-5068
Daniele PassarellaDepartment of Chemistry, Università degli Studi di Milano Via Camillo Golgi, 19 20133 Milano Italy valerio.fasano@unimi.it https://www.fasanolab.com.ORCID https://orcid.org/0000-0001-6180-9581
Valerio FasanoDepartment of Chemistry, Università degli Studi di Milano Via Camillo Golgi, 19 20133 Milano Italy valerio.fasano@unimi.it https://www.fasanolab.com.ORCID https://orcid.org/0000-0003-1819-4483
University of Milan · ITChiesi (Italy) · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Caerulomycins, natural alkaloids with antimicrobial properties, have been previously synthesized starting with highly pre-functionalized building blocks or requiring many functional group manipulations. In this work, we report the first total synthesis of caerulomycin K, a diversely trifunctionalized pyridine readily assembled in three steps exploiting the recent advancements in the C-H activation of N-heterocycles.

Identifiers

PMID38352680
PMCPMC10862659
OpenAlexW4391779181

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.